Xiamen Amoytop Biotech Co., Ltd. (SHA:688278)

China flag China · Delayed Price · Currency is CNY
86.47
-1.93 (-2.18%)
Aug 6, 2025, 1:45 PM CST
-2.18%
Market Cap35.96B
Revenue (ttm)2.95B
Net Income (ttm)880.92M
Shares Out406.80M
EPS (ttm)2.16
PE Ratio40.97
Forward PE30.83
Dividend0.62 (0.69%)
Ex-Dividend DateMay 9, 2025
Volume2,152,421
Average Volume3,724,086
Open88.03
Previous Close88.40
Day's Range85.99 - 88.60
52-Week Range46.95 - 93.52
Beta-0.35
RSI71.56
Earnings DateAug 21, 2025

About Xiamen Amoytop Biotech

Xiamen Amoytop Biotech Co., Ltd. engages in research, development, production, and sale of recombinant protein drugs in China. The company provides solutions for diseases, such as viral hepatitis, malignant tumors, and immunotherapy. Xiamen Amoytop Biotech Co., Ltd. was founded in 1996 and is based in Xiamen, China. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1996
Employees 2,423
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688278
Full Company Profile

Financial Performance

In 2024, Xiamen Amoytop Biotech's revenue was 2.82 billion, an increase of 34.13% compared to the previous year's 2.10 billion. Earnings were 827.60 million, an increase of 49.00%.

Financial Statements

News

There is no news available yet.